Mandate

Vinge advises Astrego Diagnostics AB in conjunction with capital procurement

January 29, 2020 M&A

Vinge has advised Astrego Diagnostics AB in connection with the investment in the company by the Japanese company Sysmex Corporation, which has acquired approximately 25% of the shares in the company.

Astrego develops a ground‑breaking technology for characterization of antibiotic‑sensitivity. The first product gives doctors a patient specific diagnostic tool for urinary infections.

Vinge’s team consisted of Johan Winnerblad, Kristina Ekberg and Viktoria Owetz Leyva.

Related

Vinge has advised CTEK in connection with its rights issue  

Vinge has advised CTEK AB (publ) on a fully guaranteed rights issue, which will provide CTEK with issue proceeds of approximately SEK 350 million before deduction of transaction costs.
March 29, 2023

Vinge has adviced VNV Global in connection with a rights issue

Vinge has adviced VNV Global in connection with its fully secured rights issue of approximately SEK 328 million.
March 29, 2023

Vinge advises Ramirent in connection with its acquisition of JIAB

Vinge advises Ramirent AB in connection with its acquisition of JIAB Hyrcenter (consisting of the companies JIAB Hyrcenter AB and JIAB Boden AB). Ramirent thereby further strengthens its position in Norrbotten and as the largest machine rental company in Sweden.
March 21, 2023